Ignite Creation Date:
2024-05-05 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00093639
Status:
COMPLETED
Last Update Posted:
2013-05-01
First Post:
2004-10-06
Brief Title:
Everolimus and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission After Previous Imatinib Mesylate
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis